Vascular Medicine News

The elevated propensity for peripheral artery disease in patients with major depression may be mediated by increased liability for lifetime smoking and BMI, according to research in the Journal of the American Heart Association.

Survivors of head and neck cancer had an elevated risk for stroke — regardless of age, disease site or treatment modality — study findings published in JAMA Network Open showed.

Among adults with apparent resistant hypertension, treatment with renal denervation improved left ventricular hypertrophy and LV ejection fraction but had no significant effect on diastolic function, according to a new meta-analysis.

Maintaining high levels of physical activity and weight loss were associated with reduced risks for several cardiovascular events, a study published in JAMA Network Open showed.

A miniature, three-dimensional heart model, called the “heart-on-a-chip,” successfully used reprogrammed stem cells to determine cardiotoxicity of cancer drugs on the human heart, according to a study published in Lab on a Chip.

An initiative in Michigan successfully reduced patient, physician and staff exposure to procedural radiation during percutaneous coronary intervention, and may be generalizable in other states, researchers reported.

Efemoral Medical announced the FDA granted breakthrough device status to its vascular scaffold system for treatment of de novo or restenotic lesions of the infrapopliteal arteries in patients with chronic limb-threatening ischemia.

Older adults with a coronary artery calcium score of 0 had more favorable aging indices, including normal cognitive function, vascular function and better hearing, compared with those with CAC scores of 1,000 or greater, data show.

Heart disease continues to be the leading cause of death and disability in the U.S. and worldwide. Atherosclerotic CVD, which is caused by plaque buildup in arterial walls, contributes to multiple life-threatening conditions.

Janus kinase inhibitor therapy in short durations did not significantly increase the risk for major adverse cardiovascular events or venous thromboembolism in patients with low cardiovascular risk profiles, according to a study.